IL1512

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameIL1512
Drug Alias NameIL1512IL-1512
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C chemokine receptor type 7 agonists
TargetsC-X-C chemokine receptor type 7
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIldong Pharmaceutical Co LtdiLeadBMS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiLeadBMS Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A